ArticleCancer control : journal of the Moffitt Cancer Center

The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study.

Menghua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.